Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $9000.0.

  • Kyntra Bio's Amortizatization of Intangibles rose 100000.0% to $9000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $27000.0, marking a year-over-year decrease of 9912.54%. This contributed to the annual value of $1.7 million for FY2024, which is 6680.5% down from last year.
  • As of Q3 2025, Kyntra Bio's Amortizatization of Intangibles stood at $9000.0, which was up 100000.0% from $9000.0 recorded in Q2 2025.
  • Over the past 5 years, Kyntra Bio's Amortizatization of Intangibles peaked at $2.6 million during Q1 2021, and registered a low of -$928000.0 during Q1 2022.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $176500.0 (2021), whereas its average is $543777.8.
  • As far as peak fluctuations go, Kyntra Bio's Amortizatization of Intangibles crashed by 38448.28% in 2022, and later soared by 100000.0% in 2025.
  • Over the past 5 years, Kyntra Bio's Amortizatization of Intangibles (Quarter) stood at $130000.0 in 2021, then skyrocketed by 71.54% to $223000.0 in 2022, then skyrocketed by 530.94% to $1.4 million in 2023, then plummeted by 100.07% to -$1000.0 in 2024, then skyrocketed by 1000.0% to $9000.0 in 2025.
  • Its last three reported values are $9000.0 in Q3 2025, $9000.0 for Q2 2025, and $9000.0 during Q1 2025.